Related Experiment Video
Updated: Jul 18, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity
Alicja Wiercinska-Drapalo1, Jerzy Jaroszewicz, Anna Parfieniuk
1Department of Infectious Diseases, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland. alicja@poczta.onet.pl
Regulatory Peptides
|December 26, 2006
Summary
Serum levels of pigment epithelium-derived factor (PEDF) are elevated in ulcerative colitis (UC) patients and correlate with disease severity. This suggests PEDF plays a role in UC pathogenesis.
Area of Science:
- Gastroenterology
- Molecular Biology
- Angiogenesis Research
Background:
- Pigment epithelium-derived factor (PEDF) is a key endogenous anti-angiogenic factor.
- Increased PEDF expression is observed in ulcerative colitis (UC) intestinal tissues.
- The role of serum PEDF in UC pathogenesis requires further investigation.
Purpose of the Study:
- To evaluate serum concentrations of PEDF and vascular endothelial growth factor (VEGF) in active UC patients.
- To assess the association between serum PEDF and VEGF levels and UC disease activity.
Main Methods:
- Serum samples were collected from 33 active UC patients and healthy controls.
- Concentrations of PEDF and VEGF were quantified using specific assays.
- Disease activity was assessed using endoscopic scores.
Main Results:
- UC patients exhibited significantly higher serum PEDF and VEGF levels compared to controls.
- Serum PEDF strongly correlated with endoscopic disease severity (r=0.622, P<0.001).
- No significant correlation was found between serum VEGF and disease activity (r=0.05, P=0.77).
Conclusions:
- Elevated serum PEDF in UC patients, particularly those with severe disease, indicates its involvement in UC pathogenesis.
- PEDF may serve as a potential biomarker for UC activity and severity.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...